Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation

Ann Hematol. 2011 Feb;90(2):227-9. doi: 10.1007/s00277-010-0987-0. Epub 2010 May 27.

Authors

Noemí Puig, María D Caballero, Miguel Alcoceba, Elena Sebastián, Ana Balanzategui, María E Sarasquete, Ramón García-Sanz, Marcos González-Díaz

PMID: 20506021
DOI: 10.1007/s00277-010-0987-0

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Antineoplastic Agents / therapeutic use*
Chronic Disease
Female
Graft vs Host Disease / drug therapy
Humans
Immunosuppressive Agents / therapeutic use
Lymphoma, Follicular / drug therapy*
Lymphoma, Follicular / pathology
Lymphoma, Follicular / prevention & control*
Recurrence
Remission Induction
Rituximab
Stem Cell Transplantation / adverse effects*
Transplantation Conditioning / adverse effects*
Transplantation, Homologous / adverse effects*

Substances

Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Immunosuppressive Agents
Rituximab